Abstract:Objectives Human embryonic stem cells (hESCs) serve as an attractive cell source for generating functional blood cells and hold great potential for cell-based therapy in future clinical applications. However, the underlying molecular mechanisms that regulate hESC differentiation into hematopoietic cells remain elusive. Therefore, understanding hESC differentiation is essential for the acquisition of sufficient and functional cells in vitro for successful clinical translation. Materials and Methods ELTD1 was identified as a potential mediator of hESC hematopoietic differentiation by genome-wide gene profiling. ELTD1-deleted human embryonic stem cell (hESC) lines were constructed by the iCRISPR/Cas9 technology and were used to undergo hematopoietic differentiation. Flow cytometry, quantitative RT-PCR, immunofluorescence, and RNA sequencing were used for phenotype and molecular mechanism assessment. Results Real-time PCR analysis and bioinformatic studies demonstrated that the dynamic expression of ELTD1 parallels the hemogenic endothelial progenitors-related genes expression and subsequently decreased as they differentiate into hematopoietic cells ( Figure A, C), leading us to speculate that it might play a role in hESC early hematopoietic differentiation. To further confirm these results, stage-specific cell populations at different time points were sorted to document the cell-type specificity of ELTD1. As shown in Figure B, ELTD1 was exclusively expressed in CD31 +CD34 + HEP populations. Loss-of-function studies revealed that ELTD1 deletion promoting the induction of CD31 +CD34 + HEPs at day 6, thereby promoting endothelial-to-hematopoietic transition to generate more CD43 +/CD45 + hematopoietic cells, and the results were confirmed by flow cytometry and immunofluorescence analyses ( Figure D, E and F). To dissect the molecular mechanism by which ELTD1 regulates hESC hematopoietic differentiation, the differentiated cells at day 6 were used to perform the RNA-Seq. KEGG analysis showed that hematopoietic cell lineage-related genes and Wnt signaling pathway were prominently enriched in ELTD1-deleted cells compared to WT-H1, consistent with the enhancement of HEPs and hematopoietic cells generation caused by ELTD1 deletion ( Figure G). Moreover, decreased expression of Wnt target genes: SOX17, TCF7L1, MYC, CCND1, BIRC5, and AXIN2 was further validated by quantitative RT-PCR analysis ( Figure H). To determine whether the downregulation of Wnt/β-catenin signaling is required for ELTD1 deletion-mediated enhancement of early hematopoietic differentiation from hESCs, we treated ELTD1-KO1# and ELTD1-KO2# hESCs with the Wnt agonist CHIR99021. As expected, treatment with CHIR99021 inhibited the generation of CD31 +CD34 + HEPs compared to ELTD1 deleted alone at day 6, which was validated by flow cytometry ( Figure I). Conclusions We identified ELTD1 as a novel regulator of hematopoietic differentiation, which may act via Wnt/β-catenin signaling, and provided new insights into understanding the mechanism of human hematopoiesis.

Enhanced quality of hESC‐derived melanocytes through modified concentration of endothelin‐1

Basic Fibroblast Growth Factor Combined with Endothelin-1 to Culture Normal Human Melanocytes

Differential Effects of the Extracellular Microenvironment on Human Embryonic Stem Cell Differentiation into Keratinocytes and Their Subsequent Replicative Life Span.

Directing Endothelial Differentiation of Human Embryonic Stem Cells Via Transduction with an Adenoviral Vector Expressing the VEGF165 Gene

Differentiation and Enrichment of Expandable Chondrogenic Cells from Human Embryonic Stem Cells in Vitro

Derivation of multipotent nestin + /CD271 − /STRO-1 − mesenchymal-like precursors from human embryonic stem cells in chemically defined conditions

Direct Differentiation of Atrial and Ventricular Myocytes from Human Embryonic Stem Cells by Alternating Retinoid Signals

Effects of Endothelin-1 on Melanocyte Adhesion and Migration

Effect on Actin in Melanocytes by Endothelin-1 and Stem Cell Factor

Improved Efficiency of Microsurgical Enucleated Tripronuclear Zygotes Development and Embryonic Stem Cell Derivation by Supplementing Epidermal Growth Factor, Brain-Derived Neurotrophic Factor, and Insulin-Like Growth Factor-1.

Mechanism by which endothelin-1 regulates the differentiation of P19 cells into cardiac conduction cells

ELTD1 Suppression Enhances Human Embryonic Stem Cell Hematopoiesis by Facilitating Hemogenic Endothelial Progenitor Induction Via Wnt/β-Catenin Signaling Inhibition

Effects of Feeder Cells on Dopaminergic Differentiation of Human Embryonic Stem Cells.

In vivo and in vitro study of osteogenic potency of endothelin-1 on bone marrow-derived mesenchymal stem cells

MEK1 Activation Enhances the Ex Vivo Proliferation of Haematopoietic Stem/progenitor Cell

Enamel matrix derivative expedites osteogenic differentiation of BMSCs via Wnt/β-catenin pathway in high glucose microenvironment

The combined expression of Pdx1 and MafA with either Ngn3 or NeuroD improves the differentiation efficiency of mouse embryonic stem cells into insulin-producing cells.

Differentiation of Murine Embryonic Stem Cells into Endothelial Cells Using Two-Dimensional Method and Three-Dimensional Method

Effects of EGFR-TKI on epidermal melanin unit integrity: Therapeutic implications for hypopigmented skin disorders

Optimizing mesoderm progenitor selection and three-dimensional microniche culture allows highly efficient endothelial differentiation and ischemic tissue repair from human pluripotent stem cells

Derivation, culture and retinal pigment epithelial differentiation of human embryonic stem cells using human fibroblast feeder cells